Your browser doesn't support javascript.
loading
Dynamics of replication origin over-activation.
Fu, Haiqing; Redon, Christophe E; Thakur, Bhushan L; Utani, Koichi; Sebastian, Robin; Jang, Sang-Min; Gross, Jacob M; Mosavarpour, Sara; Marks, Anna B; Zhuang, Sophie Z; Lazar, Sarah B; Rao, Mishal; Mencer, Shira T; Baris, Adrian M; Pongor, Lorinc S; Aladjem, Mirit I.
Afiliação
  • Fu H; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Redon CE; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Thakur BL; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Utani K; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Sebastian R; Department of Microbiology, Kanazawa Medical University, Uchinada Ishikawa, Kanazawa, Japan.
  • Jang SM; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Gross JM; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Mosavarpour S; Department of Biochemistry, Chungbuk National University, Chungdae-ro, Seowon-gu, Cheongju, Korea.
  • Marks AB; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Zhuang SZ; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Lazar SB; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Rao M; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Mencer ST; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Baris AM; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Pongor LS; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Aladjem MI; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Nat Commun ; 12(1): 3448, 2021 06 08.
Article em En | MEDLINE | ID: mdl-34103496
ABSTRACT
Safeguards against excess DNA replication are often dysregulated in cancer, and driving cancer cells towards over-replication is a promising therapeutic strategy. We determined DNA synthesis patterns in cancer cells undergoing partial genome re-replication due to perturbed regulatory interactions (re-replicating cells). These cells exhibited slow replication, increased frequency of replication initiation events, and a skewed initiation pattern that preferentially reactivated early-replicating origins. Unlike in cells exposed to replication stress, which activated a novel group of hitherto unutilized (dormant) replication origins, the preferred re-replicating origins arose from the same pool of potential origins as those activated during normal growth. Mechanistically, the skewed initiation pattern reflected a disproportionate distribution of pre-replication complexes on distinct regions of licensed chromatin prior to replication. This distinct pattern suggests that circumventing the strong inhibitory interactions that normally prevent excess DNA synthesis can occur via at least two pathways, each activating a distinct set of replication origins.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Origem de Replicação / Replicação do DNA Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Origem de Replicação / Replicação do DNA Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2021 Tipo de documento: Article